Grufity logoGrufity logo

HCAT

10.66USD+0.02(+0.19%)Market Closed

Health Catalyst, Inc.

Market Summary

USD10.66+0.02Market Closed
0.19%

HCAT Alerts

HCAT Stock Price

RSI Chart

Valuation

Market Cap

500.7M

Price/Earnings

-3.46

Price/Sales

1.89

Price/Cashflow

-21.26

Price/Sales

Profitability

Return on Equity

-30.89%

Return on Assets

-17.86%

Fundamentals

Revenue

Revenue (TTM)

271.8M

Revenue Y/Y

10.72%

Revenue Q/Q

-3.23%

Earnings

Earnings (TTM)

-150.6M

Earnings Y/Y

-14.3%

Earnings Q/Q

-36.82%

Price Action

52 Week Range

43.01
(Low)(High)

Last 7 days

9%

Last 30 days

31.0%

Last 90 days

-7.1%

Trailing 12 Months

-75.1%

Financial Health

Current Ratio

5.15

Investor Care

Shares Dilution (1Y)

5.18%

Diluted EPS (TTM)

-2.96

Peers (Alternatives to Health Catalyst)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
1.5T
2.6B
4.48% 38.89%
6.7K
569.2
138.91% 529.87%
515.6B
315.1B
-1.34% 21.77%
28.25
1.68
12.82% 25.96%
27.9B
5.8B
0.98% 20.75%
47.36
4.81
5.93% -26.79%
26.5B
2.0B
10.38% -33.35%
67.34
13.25
20.29% -7.22%
MID-CAP
9.0B
3.5B
11.88% 31.28%
-117.28
2.58
7.15% -34.72%
4.8B
2.3B
4.14% -69.77%
-0.48
2.14
24.79% -1114.68%
3.5B
1.3B
1.68% -71.29%
56.99
2.75
22.34% -40.14%
SMALL-CAP
1.6B
837.2M
33.66% 15.31%
26.25
1.55
-33.83% -91.80%
1.5B
245.2M
10.55% -48.84%
-8.12
5.99
36.52% -260.24%
1.3B
613.7M
3.53% 26.71%
65.1
2.15
5.58% 602.90%
862.9M
53.9M
2.02% -8.64%
69.12
16.01
16.01% 27.61%
745.9M
262.6M
6.41% 6.94%
80.59
2.84
3.32% 29.35%
500.7M
271.8M
30.96% -75.07%
-3.46
1.89
17.92% -2.29%
471.4M
317.4M
14.34% -0.77%
24.38
1.55
16.07% 16.08%
57.2M
148.3M
-15.17% -47.68%
6.43
0.39
16.33% 340.06%

Financials for Health Catalyst

Income Statement (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Revenue2.5%272265254242230
Operating Expenses2.5%281274267261251
  S&GA Expenses5.4%8984807568
  R&D Expenses6.3%7469666360
Net Income-3.9%-150.61-144.89-147.30-153.21-147.24
Balance Sheet
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Assets-4.3%776811825832846
  Current Assets-4.7%443465482508515
    Cash Equivalents-29.8%124177198193276
  Net PPE-5.6%2527252321
  Goodwill0%186186180170170
Liabilities-1.8%336342344310296
  Current Liabilities0.8%91909393263
    LT Debt, Non Current0.2%226226225181-
Shareholder's Equity-6.2%440469481522549
  Retained Earnings-5.0%-963.24-917.51-884.08-878.86-829.87
  Additional Paid-In Capital1.2%1,4041,3871,3651,4011,379
Accumulated Depreciation16.8%1816141112
Shares Outstanding0.3%5454535352
* denotes actual numbers (not divided by Millions)
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q32022Q22022Q12021Q42021Q3
Cashflow From Operations-28.3%-30.22-23.55-18.82-23.12-17.49
  Share Based Compensation-0.3%7070706559
Cashflow From Investing53.4%-121.96-261.57-175.40-139.68-84.90
Cashflow From Financing-99.7%1257260264267

Risks

What is the probability of a big loss on HCAT?

75.7%


Probability that Health Catalyst stock will be more than 20% underwater in next one year

69.5%


Probability that Health Catalyst stock will be more than 30% underwater in next one year.

61.6%


Probability that Health Catalyst stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does HCAT drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Health Catalyst was unfortunately bought at previous high price.

Returns

Cumulative Returns on HCAT

-35.3%


3-Year Cumulative Returns

Which funds bought or sold HCAT recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2022-11-23
Repertoire Partners LP
REDUCED
-98
-715,000
10,000
-%
2022-11-21
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
-
-
-296,000
617,000
-%
2022-11-16
ASHFORD CAPITAL MANAGEMENT INC
SOLD OFF
-100
-12,010,000
-
-%
2022-11-16
CAPTRUST FINANCIAL ADVISORS
SOLD OFF
-100
-19,000
-
-%
2022-11-15
ALLIANCEBERNSTEIN L.P.
REDUCED
-96.99
-63,377,000
1,301,000
-%
2022-11-15
STATE STREET CORP
ADDED
1.06
-5,270,000
11,022,000
-%
2022-11-15
JACOBS LEVY EQUITY MANAGEMENT, INC
NEW
-
5,216,000
5,216,000
0.04%
2022-11-15
Baird Financial Group, Inc.
SOLD OFF
-100
-231,000
-
-%
2022-11-15
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO
NEW
-
604,000
604,000
-%
2022-11-15
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO
NEW
-
762,000
762,000
-%

1–10 of 36

Latest Funds Activity

Are funds buying HCAT calls or puts?
Are funds bullish or bearish(Calls - Puts)?
No. of funds that own HCAT

Health Catalyst News

MarketBeat

Health Catalyst, Inc. (NASDAQ:HCAT) Short Interest Down 13.0% in November.13 minutes ago

GuruFocus.com

HCAT Fair Value

Recent SEC filings of Health Catalyst

View All Filings
Date Filed Form Type Document
Nov 17, 2022
4
Insider Trading
Nov 14, 2022
4
Insider Trading
Nov 09, 2022
10-Q
Quarterly Report
Nov 08, 2022
8-K
Current Report
Nov 03, 2022
SC 13G
Major Ownership Report
Oct 20, 2022
4
Insider Trading
Sep 19, 2022
4
Insider Trading
Sep 12, 2022
3
Insider Trading
Sep 12, 2022
4
Insider Trading
Sep 08, 2022
4
Insider Trading

Latest Insider Trading transactions for HCAT

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2022-11-15
Llewelyn Linda
SOLD
-7,235.57
10.8155
-669
Chief People Officer
2022-11-11
Burton Daniel D.
BOUGHT
1,998,210
10.1392
197,078
Chief Executive Officer
2022-10-18
Llewelyn Linda
SOLD
-6,175.44
9.53
-648
Chief People Officer
2022-09-15
Llewelyn Linda
SOLD
-7,121.52
10.99
-648
Chief People Officer
2022-09-08
Burton Daniel D.
BOUGHT
996,970
10.9859
90,750
Chief Executive Officer
2022-09-08
Freeman Kevin Lee
ACQUIRED
-
-
120,000
Chief Growth Officer
2022-09-06
Orenstein Daniel H.
SOLD
-31,978
11.2678
-2,838
General Counsel
2022-09-06
Alger Jason
SOLD
-2,955.39
11.2801
-262
Chief Accounting Officer
2022-09-01
Llewelyn Linda
SOLD (Taxes)
-9,841.04
11.605
-848
Chief People Officer
2022-09-01
Hunt Bryan Truman
SOLD (Taxes)
-16,409.5
11.605
-1,414
Chief Financial Officer

1–10 of 50

Daniel D. Burton
1200
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its solutions include a cloud-based data platform, analytics software, and professional services. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. The company was founded in 2008 and is headquartered in South Jordan, Utah.

HCAT Income Statement

2022-09-30
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Revenue:    
Revenue[1]$ 68,354$ 61,737$ 207,074$ 177,210
Cost of revenue, excluding depreciation and amortization:    
Total cost of revenue, excluding depreciation and amortization36,34033,086104,94390,477
Operating expenses:    
Sales and marketing25,40120,80867,14153,164
Research and development20,77016,38556,06645,254
General and administrative19,19223,05645,55160,596
Depreciation and amortization12,37210,65136,63326,604
Total operating expenses77,73570,900205,391185,618
Loss from operations(45,721)(42,249)(103,260)(98,885)
Interest and other income (expense), net142(4,423)(2,700)(12,082)
Loss before income taxes(45,579)(46,672)(105,960)(110,967)
Income tax provision (benefit)156(6,658)(4,339)(6,749)
Net loss$ (45,735)$ (40,014)$ (101,621)$ (104,218)
Net loss per share, basic (in USD per share)$ (0.84)$ (0.82)$ (1.89)$ (2.27)
Net loss per share, diluted (in USD per share)$ (0.84)$ (0.82)$ (1.97)$ (2.27)
Weighted-average number of shares used in calculating net loss per share, basic (in shares)54,303,66748,998,54853,666,66745,937,227
Weighted-average shares outstanding used in calculating net loss per share, diluted (in shares)54,303,66748,998,54854,024,69745,937,227
Technology    
Revenue:    
Revenue[1]$ 43,997$ 38,262$ 131,624$ 107,630
Cost of revenue, excluding depreciation and amortization:    
Total cost of revenue, excluding depreciation and amortization14,57212,09441,89534,766
Professional services    
Revenue:    
Revenue[1]24,35723,47575,45069,580
Cost of revenue, excluding depreciation and amortization:    
Total cost of revenue, excluding depreciation and amortization$ 21,768$ 20,992$ 63,048$ 55,711
[1]Includes amounts attributable to related party transactions. See Note 16 for further details.

HCAT Balance Sheet

2022-09-30
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Current assets:  
Cash and cash equivalents$ 124,224$ 193,227
Short-term investments255,918251,754
Accounts receivable, net49,54448,801
Prepaid expenses and other assets13,76414,609
Total current assets443,450508,391
Property and equipment, net25,04223,316
Intangible assets, net100,653104,788
Operating lease right-of-use assets17,25421,133
Goodwill185,982169,972
Other assets3,8194,496
Total assets776,200832,096
Current liabilities:  
Accounts payable6,8164,693
Accrued liabilities24,40523,725
Deferred revenue56,38156,632
Operating lease liabilities3,4643,425
Contingent consideration liabilities04,576
Total current liabilities91,06693,051
Convertible senior notes226,147180,942
Deferred revenue, net of current portion315929
Operating lease liabilities, net of current portion18,58620,244
Contingent consideration liabilities, net of current portion014,719
Other liabilities120113
Total liabilities336,234309,998
Commitments and contingencies (Note 14)
Stockholders’ equity:  
Preferred stock, $0.001 par value per share; 25,000,000 shares authorized as of September 30, 2022 and December 31, 2021; no shares issued and outstanding as of September 30, 2022 and December 31, 202100
Common stock, $0.001 par value per share; 500,000,000 shares authorized as of September 30, 2022 and December 31, 2021; 54,213,795 and 52,622,080 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively5453
Additional paid-in capital1,404,0321,400,972
Accumulated deficit(963,241)(878,860)
Accumulated other comprehensive loss(879)(67)
Total stockholders’ equity439,966522,098
Total liabilities and stockholders’ equity$ 776,200$ 832,096